GEVO
Price
$1.40
Change
-$0.03 (-2.11%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
339.56M
44 days until earnings call
Intraday BUY SELL Signals
LYB
Price
$57.60
Change
-$0.92 (-1.57%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
18.59B
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GEVO vs LYB

GEVO vs LYB Comparison Chart in %
View a ticker or compare two or three
VS
GEVO vs. LYB commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEVO is a StrongBuy and LYB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GEVO: $1.42 vs. LYB: $57.60)
Brand notoriety: GEVO and LYB are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: GEVO: 91% vs. LYB: 85%
Market capitalization -- GEVO: $345.64M vs. LYB: $18.59B
GEVO [@Chemicals: Specialty] is valued at $345.64M. LYB’s [@Chemicals: Specialty] market capitalization is $18.59B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $238.9B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $12.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEVO’s FA Score shows that 0 FA rating(s) are green whileLYB’s FA Score has 2 green FA rating(s).

  • GEVO’s FA Score: 0 green, 5 red.
  • LYB’s FA Score: 2 green, 3 red.
According to our system of comparison, LYB is a better buy in the long-term than GEVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GEVO’s TA Score shows that 4 TA indicator(s) are bullish while LYB’s TA Score has 4 bullish TA indicator(s).

  • GEVO’s TA Score: 4 bullish, 4 bearish.
  • LYB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GEVO is a better buy in the short-term than LYB.

Price Growth

GEVO (@Chemicals: Specialty) experienced а -0.70% price change this week, while LYB (@Chemicals: Specialty) price change was -7.97% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.31%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +16.77%.

Reported Earning Dates

GEVO is expected to report earnings on Aug 06, 2026.

LYB is expected to report earnings on Jul 31, 2026.

Industries' Descriptions

@Chemicals: Specialty (-1.31% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYB($18.6B) has a higher market cap than GEVO($340M). LYB YTD gains are higher at: 36.049 vs. GEVO (-29.000). LYB has higher annual earnings (EBITDA): 1.29B vs. GEVO (15.6M). LYB has more cash in the bank: 2.64B vs. GEVO (78.9M). GEVO has less debt than LYB: GEVO (170M) vs LYB (14.3B). LYB has higher revenues than GEVO: LYB (29.7B) vs GEVO (174M).
GEVOLYBGEVO / LYB
Capitalization340M18.6B2%
EBITDA15.6M1.29B1%
Gain YTD-29.00036.049-80%
P/E RatioN/A98.77-
Revenue174M29.7B1%
Total Cash78.9M2.64B3%
Total Debt170M14.3B1%
FUNDAMENTALS RATINGS
GEVO vs LYB: Fundamental Ratings
GEVO
LYB
OUTLOOK RATING
1..100
7350
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
382
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LYB's Valuation (6) in the Chemicals Specialty industry is somewhat better than the same rating for GEVO (70). This means that LYB’s stock grew somewhat faster than GEVO’s over the last 12 months.

LYB's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as GEVO (100). This means that LYB’s stock grew similarly to GEVO’s over the last 12 months.

LYB's SMR Rating (94) in the Chemicals Specialty industry is in the same range as GEVO (94). This means that LYB’s stock grew similarly to GEVO’s over the last 12 months.

LYB's Price Growth Rating (59) in the Chemicals Specialty industry is in the same range as GEVO (64). This means that LYB’s stock grew similarly to GEVO’s over the last 12 months.

LYB's P/E Growth Rating (2) in the Chemicals Specialty industry is somewhat better than the same rating for GEVO (38). This means that LYB’s stock grew somewhat faster than GEVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GEVOLYB
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 6 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 22 days ago
59%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
GEVO
Daily Signal:
Gain/Loss:
LYB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDIO2.150.18
+9.14%
Cardio Diagnostics Holdings Inc.
PD8.490.25
+3.03%
PagerDuty
ZS126.172.11
+1.70%
Zscaler
BOTJ24.610.21
+0.86%
Bank of the James Financial Group
GBDC12.320.03
+0.24%
Golub Capital BDC

GEVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with AMTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then AMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEVO
1D Price
Change %
GEVO100%
-7.79%
AMTX - GEVO
41%
Loosely correlated
-4.85%
CLMT - GEVO
38%
Loosely correlated
+1.90%
RPC - GEVO
38%
Loosely correlated
-1.47%
LYB - GEVO
30%
Poorly correlated
-2.58%
GPRE - GEVO
28%
Poorly correlated
+1.72%
More